Quantcast
Last updated on April 18, 2014 at 6:30 EDT

Latest Kensey Johns Stories

2012-05-02 18:21:44

EXTON, Pa., May 3, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY), today announced that it has entered into a definitive agreement with Royal DSM (DSM) (NYSE Euronext: DSM KON), under which DSM has agreed to acquire all of the common stock of Kensey Nash through a cash tender offer, followed by a merger with a subsidiary of DSM, for $38.50 per share in cash. "We are very pleased to have entered into the merger agreement with DSM, as the transaction will deliver significant...

2012-04-24 10:24:39

EXTON, Pa., April 24, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) today announced that it will release its earnings results for its third quarter ended March 31, 2012 at 7:00 A.M. Eastern Time on Thursday, May 3, 2012. Joe Kaufmann, President and CEO, will be hosting a teleconference discussing the earnings results on Thursday, May 3, 2012 at 9:00 A.M. Eastern Time. To participate in the teleconference call, please dial 612-332-0523. Individuals interested in listening...

2012-04-24 10:24:36

EXTON, Pa., April 24, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY), a leading medical technology company that provides innovative resorbable biomaterial technology for a wide range of medical procedures, today announced the achievement of several milestones for its Meso BioMatrix(TM) surgical mesh including the first clinical implant of the product. The Meso BioMatrix(TM) product is indicated for use in the United States for implantation to reinforce soft tissue where weakness...

2012-03-12 16:05:00

EXTON, Pa., March 12, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Sidoti & Company Sixteenth Annual New York Institutional Investor Forum on Monday, March 19, 2012 at The Grand Hyatt Hotel in New York. Joseph W. Kaufmann, Kensey Nash's Chief Executive Officer, will deliver the Company's presentation, beginning approximately at 10:40 a.m. (ET). The presentation materials will be available on the company's website (www.kenseynash.com)...

2012-02-03 12:41:00

EXTON, Pa., Feb. 3, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Canaccord Genuity Musculoskeletal Conference held on Tuesday, February 7, 2012 at Parc 55 in San Francisco, California. Joseph W. Kaufmann, Kensey Nash's President and CEO, will deliver the Company's presentation, beginning approximately at 10:40 a.m. (PT). The presentation materials will be available on the company's website (www.kenseynash.com) beginning at 10:40 a.m. (PT) on...

2012-01-17 14:17:00

EXTON, Pa., Jan. 17, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) today announced that it will release its earnings results for its second quarter ended December 31, 2011 at 7:00 A.M. Eastern Time on Thursday, February 2, 2012. Joe Kaufmann, President and CEO, will be hosting a teleconference discussing the earnings results on Thursday, February 2, 2012 at 9:00 A.M. Eastern Time. To participate in the teleconference call, please dial 703-639-1429. Individuals...

2011-12-16 06:30:00

EXTON, Pa., Dec. 16, 2011 /PRNewswire/ -- Kensey Nash Corporation (NASDAQ: KNSY) today announced that it has agreed with St. Jude Medical to enter into non-binding mediation in an attempt to resolve disputes over royalty payments to Kensey Nash relating to the Angio-Seal vascular closure device, as well as other related claims. Kensey Nash has repeatedly advised St. Jude that the royalties are currently to be paid, and should since 2007 have been paid, at a rate of 8% rather than the 6% rate...

2011-12-12 07:00:00

EXTON, Pa., Dec. 12, 2011 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) today announced that it was recently informed by Spectranetics Corporation (Nasdaq: SPNC) that they reached a cumulative $20 million in end-user sales of the endovascular product lines purchased from Kensey Nash in May 2008. Accordingly, this triggered achievement of a $6 million milestone payable to Kensey Nash. As previously disclosed, the Company expects to record approximately $5 million as revenue for the...

2011-11-07 07:00:00

EXTON, Pa., Nov. 7, 2011 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) today announced that it received a Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH). The NIH has awarded Kensey Nash Corporation a two-year, $1.9 million Phase II SBIR grant to further investigate the use of a bioadhesive surgical mesh for applications in tendon repair procedures. The Company will develop and evaluate the ability of its proprietary bioadhesive...

2011-10-25 08:36:00

EXTON, Pa., Oct. 25, 2011 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the following investor conferences in November. Douglas G. Evans, Kensey Nash's Chief Operating Officer, will deliver the Company's presentation, at the Sidoti and Company, LLC Fourth Annual New York Conference at The Grand Hyatt Hotel in New York on Thursday, November 10th, 2011 at 9:20 a.m. (ET). The presentation materials will be available on the company's website...